MARKET

IONS

IONS

Ionis Pharmaceuticals
NASDAQ
81.68
-0.13
-0.16%
After Hours: 80.75 -0.93 -1.14% 18:34 12/05 EST
OPEN
82.19
PREV CLOSE
81.81
HIGH
82.44
LOW
80.64
VOLUME
1.71M
TURNOVER
--
52 WEEK HIGH
83.61
52 WEEK LOW
23.95
MARKET CAP
13.23B
P/E (TTM)
-47.6602
1D
5D
1M
3M
1Y
5Y
1D
Pharvaris Stock Gains on HAE Drug Meeting Late-Stage Study Goals
NASDAQ · 1d ago
What Does the Market Think About Ionis Pharmaceuticals Inc?
Benzinga · 1d ago
Ionis Pharmaceuticals Director Joseph H. Wender Reports Sale of Common Shares
Reuters · 2d ago
Pharvaris Pill Provides Rapid Relief In Patients With Rare Swelling Attacks, Data Shows
Benzinga · 2d ago
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP), Akebia Therapeutics (AKBA) and Ionis Pharmaceuticals (IONS)
TipRanks · 3d ago
Ionis Pharmaceuticals: Promising Growth Driven by Key Product Launches and Strategic Partnerships
TipRanks · 3d ago
Ionis gets FDA breakthrough therapy status for zilganersen
Seeking Alpha · 3d ago
Ionis Pharma: FDA Grants Breakthrough Therapy Designation To Zilganersen
NASDAQ · 4d ago
More
About IONS
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults. SPINRAZA is used for the treatment of pediatric and adult patients with spinal muscular atrophy. QALSODY is approved for the treatment of Amyotrophic Lateral Sclerosis in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene, or SOD1-ALS. TEGSEDI is approved for the treatment of ATTRv-PN in adults. WAYLIVRA is approved as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk of acute, potentially fatal pancreatitis.

Webull offers Ionis Pharmaceuticals Inc stock information, including NASDAQ: IONS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IONS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IONS stock methods without spending real money on the virtual paper trading platform.